William P. Noglows - Apr 30, 2025 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)

Role
Director
Signature
/s/ Virginia H. Johnson, Attorney-in-Fact
Stock symbol
ASPN
Transactions as of
Apr 30, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 08:51 PM
Previous filing
Apr 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASPN Common Stock Award $0 +10.4K +13.19% $0.00 89K Apr 30, 2025 Direct F1, F2
holding ASPN Common Stock 10K Apr 30, 2025 See footnote 3 F3
holding ASPN Common Stock 10K Apr 30, 2025 See footnote 4 F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASPN Stock Options (Right to Buy) Award $0 +9.11K $0.00 9.11K Apr 30, 2025 Common Stock 9.11K $5.40 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs will vest on the earlier of (a) April 30, 2026, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2026.
F2 Represents 78,617 shares of Common Stock and 10,370 RSUs.
F3 These shares of Common Stock are held by a Trust for the benefit of one of the reporting person's children, of which the reporting person is the Trustee.
F4 These shares of Common Stock are held by a Trust for the benefit of another one of the reporting person's children, of which the reporting person is the Trustee.
F5 The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) April 30, 2026, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2026.